A4S SOLUTIONS LIMITED
Opportunity 65/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Confirmation statement overdue. Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Total assets | £11.0k | — |
| Current assets | £15 | — |
| Net assets | £11.0k | — |
| Average employees | — | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 1 accounts
- • 1 accounts
- • 2 accounts
Corporate timeline (18 events)Click to expand
- 2026-05-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-12-02📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-10-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-07-27📄gazette-filings-brought-up-to-dategazette · DISS40
- 2024-07-16📄gazette-notice-compulsorygazette · GAZ1
- 2023-10-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-12-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-11-12📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-10-16📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-12-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-09-23📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2019-01-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-10-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-04-06📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2017-01-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2015-09-22🏢Company incorporatedAs A4S SOLUTIONS LIMITED
- 2015-09-22➕KHAN, Ameera Shahid appointeddirector
- 2015-09-22➕SHAMIM, Aamer, Dr appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +No director turnover: Company is 11 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
1 high ·Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.
Evidence: Next due: 2026-05-14
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Ameera Shahid Khan Individual · British · DOB 04/1976 · age 50 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 01/07/2016 |
Dr Aamer Shamim Individual · British · DOB 09/1977 · age 49 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 01/07/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · WA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 121HT LTD→ 16310335 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| 21D CLINICAL LIMITED→ 09476584 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| 23D GROUP LIMITED→ 17128365 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| 2B WELL CONSULTING LTD→ 15289841 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| 4 SEASONS MEDICAL CENTRE LTD→ 03679849 · est 1998 · no financials extracted | — | — | — | — | 27y | — | — |
| 964 DENT LTD→ 13668310 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| A3S MEDICARE LTD→ 10645414 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| AB ADVANCED PRACTICE LIMITED→ 11438195 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ABL SUPPORT LTD→ 10124506 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ABLE SUPPORT LTD→ 05511903 · est 2005 · no financials extracted | — | — | — | — | 20y | — | — |
| ABSOLUTE OCCUPATIONAL HEALTH LTD→ 11337959 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ACADIA PHARMA LIMITED→ 09732216 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.